B Van Camp

1.9k total citations
52 papers, 1.5k citations indexed

About

B Van Camp is a scholar working on Hematology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, B Van Camp has authored 52 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 18 papers in Molecular Biology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in B Van Camp's work include Multiple Myeloma Research and Treatments (18 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Chronic Lymphocytic Leukemia Research (9 papers). B Van Camp is often cited by papers focused on Multiple Myeloma Research and Treatments (18 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Chronic Lymphocytic Leukemia Research (9 papers). B Van Camp collaborates with scholars based in Belgium, United States and France. B Van Camp's co-authors include M. De Waele, Ivan Van Riet, Karin Vanderkerken, Rik Schots, Kewal Asosingh, Patrick Lacor, L. Kaufman, Hendrik De Raeve, Johan De Mey and Wim Renmans and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Infectious Diseases.

In The Last Decade

B Van Camp

51 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Van Camp Belgium 23 720 508 381 267 181 52 1.5k
John L. Francis United States 23 996 1.4× 437 0.9× 391 1.0× 428 1.6× 130 0.7× 75 2.6k
Daniel H. Ryan United States 21 616 0.9× 589 1.2× 298 0.8× 596 2.2× 438 2.4× 69 2.1k
Torsten Keßler Germany 26 529 0.7× 950 1.9× 685 1.8× 197 0.7× 182 1.0× 92 2.1k
Paul A. Chervenick United States 21 665 0.9× 254 0.5× 466 1.2× 493 1.8× 182 1.0× 40 1.7k
Jay N. Lozier United States 27 1.1k 1.5× 926 1.8× 421 1.1× 371 1.4× 186 1.0× 65 2.6k
Michael J. Mant Canada 26 1.1k 1.5× 918 1.8× 437 1.1× 501 1.9× 207 1.1× 71 2.2k
Denis Cournoyer Canada 23 343 0.5× 708 1.4× 434 1.1× 279 1.0× 304 1.7× 42 1.5k
Lori Anderson United States 14 821 1.1× 422 0.8× 378 1.0× 540 2.0× 43 0.2× 25 1.9k
Markéta Jiroušková United States 18 604 0.8× 352 0.7× 582 1.5× 276 1.0× 73 0.4× 32 1.8k
G Wong Canada 18 671 0.9× 433 0.9× 820 2.2× 578 2.2× 109 0.6× 22 2.0k

Countries citing papers authored by B Van Camp

Since Specialization
Citations

This map shows the geographic impact of B Van Camp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Van Camp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Van Camp more than expected).

Fields of papers citing papers by B Van Camp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Van Camp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Van Camp. The network helps show where B Van Camp may publish in the future.

Co-authorship network of co-authors of B Van Camp

This figure shows the co-authorship network connecting the top 25 collaborators of B Van Camp. A scholar is included among the top collaborators of B Van Camp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Van Camp. B Van Camp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Camp, B Van, et al.. (2025). Budd-Chiari syndrome from pleomorphic sarcoma compressing the inferior vena cava: A case report. Radiology Case Reports. 20(10). 5161–5164.
2.
Raeve, Hendrik De, Eric Van Marck, B Van Camp, & Karin Vanderkerken. (2004). Angiogenesis and the role of bone marrow endothelial cells in haematological malignancies.. PubMed. 19(3). 935–50. 32 indexed citations
3.
Broek, Isabelle Vande, Kewal Asosingh, Xavier Leleu, et al.. (2004). Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor. Leukemia. 18(5). 976–982. 62 indexed citations
4.
Menu, Eline, Ron Kooijman, Els Van Valckenborgh, et al.. (2004). Specific roles for the PI3K and the MEK–ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model. British Journal of Cancer. 90(5). 1076–1083. 96 indexed citations
5.
6.
Raeve, Hendrik De, Mark Perry, C M Shipman, et al.. (2002). Zoledronic acid prevents the development of osteolytic bone disease and increases survival in a murine model of multiple myeloma. Bone. 30. 3 indexed citations
7.
Croucher, Peter I., C M Shipman, Mark Perry, et al.. (2001). Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma. Bone. 28(5). 1 indexed citations
8.
Croucher, Peter I., C M Shipman, Mark Perry, et al.. (2001). Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma. Blood. 98. 6 indexed citations
9.
10.
Croucher, Peter I., C M Shipman, Mark Perry, et al.. (2000). Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.. Blood. 96(11). 1 indexed citations
11.
Bellahcène, Akeila, Ivan Van Riet, Catherine De Greef, et al.. (2000). Bone sialoprotein mRNA and protein expression in human multiple myeloma cell lines and patients. British Journal of Haematology. 111(4). 1118–1121. 9 indexed citations
12.
Schots, Rik, L. Kaufman, Ivan Van Riet, et al.. (1998). Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality. Bone Marrow Transplantation. 22(1). 79–85. 42 indexed citations
13.
Vanderkerken, Karin, E Goes, Hendrik De Raeve, J Rádl, & B Van Camp. (1996). Follow-up of bone lesions in an experimental multiple myeloma mouse model: description of an in vivo technique using radiography dedicated for mammography. British Journal of Cancer. 73(12). 1463–1465. 33 indexed citations
14.
Meysman, Marc, et al.. (1993). Systemic amyloidosis-induced diarrhea in sex-linked agammaglobulinemia.. PubMed. 88(8). 1275–7. 2 indexed citations
15.
Heirman, Carlo, et al.. (1992). Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood. 80(9). 2326–2335. 5 indexed citations
16.
Riet, Ivan Van, M. De Waele, L. Remels, et al.. (1991). Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells. British Journal of Haematology. 79(3). 421–427. 90 indexed citations
17.
Riet, Ivan Van, et al.. (1990). Immunomagnetic Purging of Bone Marrow Grafts for Autologous Transplantation in Neuroblastoma. Acta Clinica Belgica. 45(2). 97–106. 2 indexed citations
18.
Lacor, Patrick, et al.. (1990). Malignant Lymphoma of the Bone. Acta Clinica Belgica. 45(6). 386–393. 3 indexed citations
19.
Waele, M. De, et al.. (1988). Sensitive detection of immunogold-silver staining with darkfield and epi-polarization microscopy.. Journal of Histochemistry & Cytochemistry. 36(6). 679–683. 32 indexed citations
20.
Bloem, A C, Meera Chand, B Van Camp, E. J. E. G. Bast, & R. E. Ballieux. (1986). Mitogenic stimulation of malignant B cells Waldenstrøm's macroglobulinaemia: secretion of monoclonal IgM by in vitro-induced plasmablasts.. PubMed. 63(1). 156–62. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John L. Francis Breakdown of academic impact, for papers by Daniel H. Ryan Breakdown of academic impact, for papers by Torsten Keßler Breakdown of academic impact, for papers by Paul A. Chervenick Breakdown of academic impact, for papers by Jay N. Lozier Breakdown of academic impact, for papers by Michael J. Mant Breakdown of academic impact, for papers by Denis Cournoyer Breakdown of academic impact, for papers by Lori Anderson Breakdown of academic impact, for papers by Markéta Jiroušková Breakdown of academic impact, for papers by G Wong
Rankless by CCL
2026